Index Every US public charity, on the record

Pediatric Cancer Research Foundation

Irvine, California
EIN 95-3772528Grantmaking public charityLatest return year ending June 2025Its profile as a public charity

Applications

Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Pediatric Cancer Research Foundation accepts applications.

From its returns

What it gave

Pediatric Cancer Research Foundation paid $1,695,918 in grants in the year ending June 2025.

Grants paid
$1,695,918
Year ending June 2025
Grants listed
15
To organizations, on that return
Typical grant
$45,000
Half fall between $31,000 and $100,000
Year endingGrants paidGrants listed
June 2025$1,695,91815
June 2024$914,81314

From Schedule I of its Form 990 returns for the years ending June 2024 to June 2025.

Focus and places

What it funds, and where

From the 29 grants listed on its returns for the years ending June 2024 to June 2025. A grant counts toward a focus only when it is linked to the charity that received it: 10 of 29 are.

Focus, by share of linked grant dollars

  • Medical research70%
  • Health care28%
  • Human services1%

Where it gave, by number of grants

  • California12
  • New York5
  • Massachusetts2
  • Ohio2
  • Maryland2
  • Indiana2
  • District of Columbia2
  • North Carolina1
  • Pennsylvania1

From Schedule I of its Form 990 returns for the years ending June 2024 to June 2025.

Grants

Recent grants to organizations

The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.

RecipientYear endingAmountPurpose
NEW YORK MEDICAL COLLEGEValhalla, New YorkJune 2025$550,000PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE
The V FoundationCary, North CarolinaJune 2025$204,000CANCER RESEARCH
MEMORIAL SLOAN KETTERINGNew York, New YorkJune 2025$150,000TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS
City of Hope National Medical CenterDuarte, CaliforniaJune 2025$100,000SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Dana-Farber Cancer InstituteBoston, MassachusettsJune 2025$100,000ADVANCING LIQUID BIOPSIES TO THE CLINIC FOR PATIENTS WITH EWING SARCOMA
STANFORDPalo Alto, CaliforniaJune 2025$100,000TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML
JOHNS HOPKINSBaltimore, MarylandJune 2025$100,000TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA
UNIVERSITY OF CALIFORNIA SAN FRANCISCOSan Francisco, CaliforniaJune 2025$45,000A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA
CHILDREN'S HOSPITAL LOS ANGELESLos Angeles, CaliforniaJune 2025$37,500PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS
CASE WESTERNClevenland, OhioJune 2025$37,500USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS
CHILDREN'S HOSPITAL LOS ANGELESLos Angeles, CaliforniaJune 2025$32,000RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE OF AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER
Hope for Henry FoundationWashington, District of ColumbiaJune 2025$30,000REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE
INDIANA UNIVERSITYBloomington, IndianaJune 2025$27,000DECODING METABOLIC DEPENDENCIES OF MPNSTS AND ITS MICROENVIRONMENT
Ronald McDonald House Charities of Southern CaliforniaLos Angeles, CaliforniaJune 2025$25,000WILDFIRE RECOVERY FUNDING FOR FAMILIES OF CANCER PATIENTS AT THE LOS ANGELES RONALD MCDONALD HOUSE
Live for Liv FoundationWestford, MassachusettsJune 2025$8,000SUPPORTS CHILDREN AND FAMILIES DEALING WITH SERIOUS CONDITIONS
NEW YORK MEDICAL COLLEGEValhalla, New YorkJune 2024$275,000PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE
MEMORIAL SLOAN KETTERINGNew York, New YorkJune 2024$75,000TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS
City of Hope National Medical CenterDuarte, CaliforniaJune 2024$50,000SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Dana-Farber Cancer InstituteBoston, MassachusettsJune 2024$50,000PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA
STANFORD UNIVERSITYPalo Alto, CaliforniaJune 2024$50,000TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML
JOHNS HOPKINS UNIVERSITYBaltimore, MarylandJune 2024$50,000TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA
Hope for Henry FoundationWashington, District of ColumbiaJune 2024$49,563REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE
UCSFSan Francisco, CaliforniaJune 2024$40,000TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA
CHILDREN'S HOSPITAL OF LOS ANGELESLos Angeles, CaliforniaJune 2024$37,500PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS
CASE WESTERNClevenland, OhioJune 2024$37,500USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS

Showing 25 of the 29 grants listed on its returns for the years ending June 2024 to June 2025. From Schedule I of its Form 990 returns for the years ending June 2024 to June 2025.